Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Healius Limited ( (AU:HLS) ) has issued an announcement.
Healius Limited has announced the approval of its amended Constitution by shareholders at the 2025 Annual General Meeting. This amendment, which includes the reinsertion of proportional takeover approval provisions, reflects ongoing adjustments to the company’s governance framework, potentially impacting its operational and strategic direction.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is one of Australia’s leading healthcare companies, dedicated to providing quality, affordable, and accessible healthcare services. With over 30 years in the industry, Healius operates a wide network of centers and employs more than 8,000 people to deliver specialty pathology services across Australia.
Average Trading Volume: 4,815,348
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$580.9M
See more insights into HLS stock on TipRanks’ Stock Analysis page.